N-ERD | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

11,243 results for “N-ERD”

Trials

View all 6340 →

Not yet recruiting

Long-term Effect of Dupilumab in N-ERD

30 participants · First posted Jul 3, 2025

Characterisation of the Nasal Microbiome in Patients With N-ERD

80 participants · First posted May 5, 2020

ERd Combination Treatment in Newly Diagnosed Multiple Myeloma

104 participants · First posted May 30, 2025

Drugs

View all 2555 →

ERD-1233

ERD-308

ERD-3111

Organizations

View all 130 →

N&N Pharmaceuticals, Inc.

United States

n-Lorem Foundation

United States

Steve N Caritis Md

United States

News

View all 2218 →

Aspirin Therapy Shows No Significant Benefit for Chronic Rhinosinusitis with Nasal Polyps in Randomized Trial

Erdafitinib Shows Promising Early Efficacy and Manageable Safety Profile in FGFR-TACC Fusion-Positive Glioma

Erdafitinib Approved in the UK for Advanced Bladder Cancer with FGFR3 Alterations

Page 1 of 1125